Keyword: Olivier Brandicourt
Sanofi's CFO search lasted two months and led the company to a financial executive from French automaker PSA Group.
Sanofi posted strong vaccines growth last year, but the first quarter of 2018 didn't deliver quite so well.
Formulary shutouts were already hurting Sanofi's diabetes numbers. But price cuts and Medicare compounded the pain in the first quarter of 2017.
Jérôme Contamine, Sanofi's CFO for nearly a decade, plans to step down later this year after a transition period.
Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."
At €350 million, Sanofi's new Canadian vaccine plant will be one of the largest investments ever by the company in a single facility.
Sanofi is out another potential buyer for its European generics business as India-based Torrent Pharma exited deal talks, according to a report.
As Sanofi presses ahead with the sale of its EU generics unit, a private equity firm has reportedly bowed out over price.
Sanofi has narrowed down the field of potential buyers to drug companies from Brazil and India, plus several private equity funds, Reuters reports.
Sanofi, aiming to sharpen its focus by offloading its EU generics, is reportedly drawing shoppers from across the globe. The deal could be worth $2B.